Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mirum Pharmaceuticals (MIRM) Shares Outstanding (Diluted Average): 2022-2024

Historic Shares Outstanding (Diluted Average) for Mirum Pharmaceuticals (MIRM) over the last 3 years, with Dec 2024 value amounting to $47.5 million.

  • Mirum Pharmaceuticals' Shares Outstanding (Diluted Average) rose 19.28% to $57.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.0 million, marking a year-over-year increase of 19.28%. This contributed to the annual value of $47.5 million for FY2024, which is 16.23% up from last year.
  • Mirum Pharmaceuticals' Shares Outstanding (Diluted Average) amounted to $47.5 million in FY2024, which was up 16.23% from $40.9 million recorded in FY2023.
  • In the past 5 years, Mirum Pharmaceuticals' Shares Outstanding (Diluted Average) registered a high of $47.5 million during FY2024, and its lowest value of $34.0 million during FY2022.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $40.9 million (2023), whereas its average is $40.8 million.
  • Data for Mirum Pharmaceuticals' Shares Outstanding (Diluted Average) shows a peak YoY rose of 20.31% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows Mirum Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $34.0 million in 2022, then climbed by 20.31% to $40.9 million in 2023, then grew by 16.23% to $47.5 million in 2024.